Idarucizumab as Antidote to Intracerebral Hemorrhage under Treatment with Dabigatran

BACKGROUND AND PURPOSE: Non-vitamin K anticoagulants (NOAC) such as dabigatran have become important therapeutic options for the prevention of stroke. Until recently, there were only nonspecific agents to reverse their anticoagulant effects in a case of emergency. Idarucizumab, an antibody fragment...

Descripción completa

Detalles Bibliográficos
Autores principales: Held, Valentin, Eisele, Philipp, Eschenfelder, Christoph C., Szabo, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121568/
https://www.ncbi.nlm.nih.gov/pubmed/27920714
http://dx.doi.org/10.1159/000452096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121568/
https://www.ncbi.nlm.nih.gov/pubmed/27920714
http://dx.doi.org/10.1159/000452096

Ejemplares similares